Shexiang Baoxin Pill Regulates Intimal Hyperplasia, Migration, and Apoptosis after Platelet-Derived Growth Factor-BB-Stimulation of Vascular Smooth Muscle Cells via miR-451.
10.1007/s11655-022-2891-6
- Author:
Yi-Ping LI
1
;
Ting-Ting QIANG
1
;
Ke-Yan WANG
1
;
Xiao-Long WANG
2
Author Information
1. Department of Cardiology, Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.
2. Department of Cardiology, Shuguang Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China. wxlqy0214@163.com.
- Publication Type:Journal Article
- Keywords:
Shexiang Baoxin Pills;
apoptosis;
miR-451;
platelet-derived growth factor-BB-stimulated vascular smooth muscle cells proliferation
- MeSH:
Apoptosis;
Becaplermin/pharmacology*;
Cell Movement;
Cell Proliferation;
Cells, Cultured;
Dimethyl Sulfoxide/pharmacology*;
Drugs, Chinese Herbal;
Humans;
Hyperplasia/metabolism*;
MicroRNAs/metabolism*;
Muscle, Smooth, Vascular;
Myocytes, Smooth Muscle;
Tumor Suppressor Protein p53/metabolism*
- From:
Chinese journal of integrative medicine
2022;28(9):785-793
- CountryChina
- Language:English
-
Abstract:
OBJECTIVE:To investigate the regulatory roles of Shexiang Baoxin Pill (SXBXW) in neointimal formation and vascular smooth muscle cells (VSMCs) invasion and apoptosis as well as the potential molecular mechanisms using cultured VSMCs model of vascular injury (platelet-derived growth factor (PDGF)-BB-stimulated) in vitro.
METHODS:VSMCs were randomly assigned to 5 groups: blank, PDGF-BB (20 ng/mL+ 0.1% DMSO), SXBXW-L (PDGF-BB 20 ng/mL + SXBXW low dose 0.625 g/L), SXBXW-M (PDGF-BB 20 ng/mL + SXBXW medium dose 1.25 g/L) and SXBXW-H (PDGF-BB 20 ng/mL+ SXBXW high dose 2.5 g/L) group. Cell proliferation was assessed using cell counting kit-8 (CCK-8) assay and bromodeoxyuridine (BrdU) incorporation assay, the migration effects were detected by Transwell assay, cell apoptosis rate was measured by the Annexin V/propidium iodide (PI) apoptosis kit. The markers of contractile phenotype of VSMCs were detected with immunofluorescent staining. To validate the effects of miR-451 in regulating proliferation, migration and apoptosis treated with SXBXW, miR-451 overexpression experiments were performed, the VSMCs were exposed to PDGF-BB 20 ng/mL + 0.1% DMSO and later divided into 4 groups: mimic-NC (multiplicity of infection, MOI=50), SXBXW (1.25 g/L) + mimic-NC, mimic-miR451 (MOI=50), and SXBXW (1.25 g/L) + mimic-miR451, and alterations of proteins related to the miR-451 pathway were analyzed using Western blot.
RESULTS:PDGF-BB induced VSMCs injury causes acceleration of proliferation and migration. SXBXW inhibited phenotypic switching, proliferation and migration and promoted cell apoptosis in PDGF-BB-induced VSMCs. In addition, miR-451 was shown to be down-regulated in the VSMCs following PDGF-BB stimulation. SXBXW treatment enhanced the expression of miR-451 in PDGF-BB-induced VSMCs (P<0.05). Compared with SXBXW + mimic-NC and mimic-miR451 groups, the expression of tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (Ywhaz) and p53 was further reduced in SXBXW + mimic-miR451 group, while activating transcription factor 2 (ATF2) was increased in VSMCs (P<0.05).
CONCLUSION:SXBXW regulated proliferation, migration and apoptosis via activation of miR-451 through ATF2, p53 and Ywhaz in PDGF-BB-stimulated VSMCs.
